HC-067047
CAS No. 883031-03-6
HC-067047( HC-067047 | HC 067047 | HC067047 )
Catalog No. M19226 CAS No. 883031-03-6
HC-067047 is a potent and selective TRPV4 antagonist.Also inhibits the endogenous TRPV4-mediated response to 4α-PDH .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 59 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 491 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHC-067047
-
NoteResearch use only, not for human use.
-
Brief DescriptionHC-067047 is a potent and selective TRPV4 antagonist.Also inhibits the endogenous TRPV4-mediated response to 4α-PDH .
-
DescriptionHC-067047 is a potent and selective TRPV4 antagonist. HC-067047 increases functional bladder capacity and reduces micturition frequency in WT mice and rats with cystitis. HC-067047 did not affect bladder function in Trpv4(-/-) mice, demonstrating that its in vivo effects are on target. HC-067047 may provide a promising means of treating bladder
-
In VitroHC-067047 (1 μM; 24 hours; HEI-OC1 cells) treatment significantly decreases mRNA expression in high glucose cultured HEI-OC1 cells.?HC-067047 (1 μM; 24 hours; HEI-OC1 cells) treatment significantly decreases the expression of TRPV4 protein.HC-067047 (1 μM; 48 hours; HEI-OC1 cells) treatment inhibits cell proliferation.HC-067047 (1 μM; 48 hours; HEI-OC1 cells) treatment promotes cell apoptosis. RT-PCR Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:24 hours Result:The mRNA expression was significantly decreased.Western Blot Analysis Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:24 hours Result:The expression of TRPV4 protein was significantly decreased.Cell Proliferation Assay Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:48 hours Result:Inhibited cell proliferation.Apoptosis Analysis Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:48 hoursResult:Promoted cell apoptosis.
-
In VivoAnimal Model:Cyclophosphamide-treated WT and Trpv4?/? mice, and naive WT miceDosage:0 mg/kg, 1 mg/kg, 10 mg/kg, 50 mg/kg Administration:Intraperitoneal injection; for 30 minutes Result:Increased functional bladder capacity and reduces micturition frequency in WT mice with cystitis and did not affect bladder function in Trpv4?/? mice.
-
SynonymsHC-067047 | HC 067047 | HC067047
-
PathwayOthers
-
TargetOther Targets
-
RecptorhTRPV4/mTRPV4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number883031-03-6
-
Formula Weight471.51
-
Molecular FormulaC26H28F3N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 106.04 mM
-
SMILESFC(F)(F)c1cc(ccc1)NC(=O)c4cc(c2ccccc2)n(CCCN3CCOCC3)c4C
-
Chemical Name2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Everaerts W et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19084-9.
molnova catalog
related products
-
Substance P (1-7) 2T...
Substance P (1-7) 2TFA(68060-49-1(free base)) is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP)with anti-inflammatory anti-nociceptive and anti-hyperalgesic effects.
-
Mefexamide hydrochlo...
Mefexamide hydrochloride is a psychostimulant.
-
Licochalcone B
Licochalcone B (LCB) inhibits the proliferation of human malignant bladder cancer cell lines (T24 and EJ) in vitro and antitumor activity in vivo in MB49 (murine bladder cancer cell line) tumor model.
Cart
sales@molnova.com